Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

INVELTYS 1% EYE DROP

loteprednol etabonate
$103.1700per ML
High Outlier

Strength

10 mg/mL

Manufacturer

Alcon Laboratories, Inc.

NDC

71571012128

Classification

Brand

Dosage Form

SUSPENSION

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

LOTEPREDNOL ETABONATE

Approval Type

New Drug (NDA)

FDA Application

NDA210565

On Market Since

8/22/2018

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price History

1W

0.0%

1M

+0.0%

3M

-0.0%

6M

+0.1%

1Y

-0.3%

3Y

-0.3%

5Y

+8.5%

All

+34.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

PREPARATION H HC 1% CREAM
Brand
00573283010•Haleon US Holdings LLC
$0.2072
per GM
MEDROL 4 MG TABLET
Brand
00009005602•Pharmacia & Upjohn Company LLC
$0.2257
per EA
DERMA-SMOOTHE-FS SCALP OIL
Brand
68791010204•Royal Pharmaceuticals
$0.2423
per ML
DERMA-SMOOTHE-FS BODY OIL
Brand
68791010104•Royal Pharmaceuticals
$0.2426
per ML
MEDROL 4 MG DOSEPAK
Brand
00009005604•Pharmacia & Upjohn Company LLC
$0.2911
per EA
CORTEF 5 MG TABLET
Brand
00009001201•Pharmacia & Upjohn Company LLC
$0.9757
per EA
DERMOTIC OIL 0.01% EAR DROPS
Brand
68791010320•Royal Pharmaceuticals
$1.1311
per ML
NASONEX 24HR ALLERGY 50 MCG NASAL SPRAY
Brand
00113172002•L. Perrigo Company
$1.1904
per ML
CHILD FLONASE ALLER RLF 50 MCG
Brand
00135058202•Haleon US Holdings LLC
$1.2091
per ML
FLONASE ALLERGY RLF 50 MCG SPR
Brand
00135057602•Haleon US Holdings LLC
$1.2148
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy